Replies to post #176179 on Innovation Pharmaceuticals Inc (IPIX)

[DaubersUP]

Brilacidin. ABSSSI - In February 2016, Cellceutix submitted a Special Protocol Assessment (SPA) request, along with a final protocol, to the FDA, for a Phase 3 clinical trial of Brilacidin for the treatment of Acute Bacterial Skin and Skin Structure Infection (ABSSSI) caused by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). We received from the FDA comments and considerations for incorporation into our study design. Management has decided to delay its response to FDA due to the low price per share of our common stock and the approximately $30 million costs required for this study which would result in significant dilution to our shareholders. Our strategy for now is to achieve success with other trials and attract partnering opportunities with significant down payments and milestone payments which can fund these trials.



LATEST 10Q


So I think they gave up the SPA talk for a bit. But I do think that the company may take a full buyout. Just a whisper. They may be aligning all of these PoC and mid phase 2 trials to show BP exactly what htey want with a guaranteed phase 3 new antibiotic sitting there and if K proves out better than expected with a good update on oral ------ we may see a huge buyout. Upwards of 17 billion outright. JMO

Long until Leo sells - CTIX

[rr50]

Friendly reminder
CTIX pipeline is not run-of-mill, me-too Compounds - 1st in Class w Platform potential in mid phase trials
B and P looking to be very competitive w biologics -- encroaching on their turf
Sure smaller trials but craploads of $ thrown at concept companies (see JUNO)
I'm betting strong Big Rx Partnering move by summertime when Topline B UPS / OM and interim P are in
Or maybe before if the C suite nellys get nervous they might risk losing out on P next (better?) Otezla, B the next (better) Humira (heard it here first) and re K -- TBD but shooting for the Moon
Formulation work is easy, finding viable Compounds - 10000 to 1 long odds
In a year or so this company is gonna look very difft if its not already been scooped for Bns
All IMO

[lousy engineer]

So now you're a CTIX permanent bear?

[AlanC]

A bigger gamble for those that are short I am sure you would agree. They have a lot to lose as they dig their hole deeper and deeper day after day.
Go CTIX!!!

[stevo99]

Hasn't B-UP already knocked it out of the park? 100% of participants improved after treatment (half of those remission). Granted it's a small sample but what other drug in this space has come close to these kinds of responses? Does BP really need an approved drug before they pounce? That's certainly not what we've seen in the past.....too hungry to latch onto the next big thing before the competition....